Iperionx Ltd (IPX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 103.51 is considered Overvalued compared with the five-year average of -73.51. The fair price of Iperionx Ltd (IPX) is between 26.75 to 47.85 according to relative valuation method. Compared to the current price of 50.50 USD , Iperionx Ltd By Overvalued By 5.54%.

Relative Value

Fair Zone

26.75-47.85

Current Price：50.50

5.54%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Iperionx Ltd (IPX) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Iperionx Ltd (IPX) has a current Price-to-Book (P/B) ratio of 138.12. Compared to its 3-year average P/B ratio of 47.90, the current P/B ratio is approximately 188.38% higher. Relative to its 5-year average P/B ratio of 33.18, the current P/B ratio is about 316.23% higher. Iperionx Ltd (IPX) has a Forward Free Cash Flow (FCF) yield of approximately -3.03%. Compared to its 3-year average FCF yield of -7.42%, the current FCF yield is approximately -59.14% lower. Relative to its 5-year average FCF yield of -8.77%, the current FCF yield is about -65.45% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for IPX competitors is 28.61, providing a benchmark for relative valuation. Iperionx Ltd Corp (IPX.O) exhibits a P/S ratio of 103.51, which is 261.75% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of IPX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IPX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IPX currently overvalued or undervalued?

What is Iperionx Ltd (IPX) fair value?

IPX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Iperionx Ltd (IPX) is between 26.75 to 47.85 according to relative valuation method.

How does IPX's valuation metrics compare to the industry average?

The average P/S ratio for IPX's competitors is 28.61, providing a benchmark for relative valuation. Iperionx Ltd Corp (IPX) exhibits a P/S ratio of 103.51, which is 261.75% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Iperionx Ltd (IPX) as of Mar 02 2026?

As of Mar 02 2026, Iperionx Ltd (IPX) has a P/B ratio of 138.12. This indicates that the market values IPX at 138.12 times its book value.

What is the current FCF Yield for Iperionx Ltd (IPX) as of Mar 02 2026?

As of Mar 02 2026, Iperionx Ltd (IPX) has a FCF Yield of -3.03%. This means that for every dollar of Iperionx Ltd's market capitalization, the company generates -3.03 cents in free cash flow.

What is the current Forward P/E ratio for Iperionx Ltd (IPX) as of Mar 02 2026?

As of Mar 02 2026, Iperionx Ltd (IPX) has a Forward P/E ratio of -532.13. This means the market is willing to pay $-532.13 for every dollar of Iperionx Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Iperionx Ltd (IPX) as of Mar 02 2026?

As of Mar 02 2026, Iperionx Ltd (IPX) has a Forward P/S ratio of 103.51. This means the market is valuing IPX at $103.51 for every dollar of expected revenue over the next 12 months.

IPX Valuation